In diabetic nephropathy (DN), TNF-α can enhance podocyte damage by activating the nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) signaling and leading to tubular epithelial cell dysfunction, thereby accelerating disease progression. Here, TNF is linked to liver dysplastic nodule.